CA2238723A1 - Arylethenesulfonamide derivatives and drug composition containing the same - Google Patents

Arylethenesulfonamide derivatives and drug composition containing the same

Info

Publication number
CA2238723A1
CA2238723A1 CA002238723A CA2238723A CA2238723A1 CA 2238723 A1 CA2238723 A1 CA 2238723A1 CA 002238723 A CA002238723 A CA 002238723A CA 2238723 A CA2238723 A CA 2238723A CA 2238723 A1 CA2238723 A1 CA 2238723A1
Authority
CA
Canada
Prior art keywords
group
atom
substituted
optionally substituted
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002238723A
Other languages
French (fr)
Other versions
CA2238723C (en
Inventor
Hironori Harada
Jun-Ichi Kazami
Susumu Watanuki
Ryuji Tsuzuki
Katsumi Sudou
Akihiro Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co., Ltd.
Hironori Harada
Jun-Ichi Kazami
Susumu Watanuki
Ryuji Tsuzuki
Katsumi Sudou
Akihiro Tanaka
Astellas Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co., Ltd., Hironori Harada, Jun-Ichi Kazami, Susumu Watanuki, Ryuji Tsuzuki, Katsumi Sudou, Akihiro Tanaka, Astellas Pharma Inc. filed Critical Yamanouchi Pharmaceutical Co., Ltd.
Priority claimed from PCT/JP1996/003701 external-priority patent/WO1997022595A1/en
Publication of CA2238723A1 publication Critical patent/CA2238723A1/en
Application granted granted Critical
Publication of CA2238723C publication Critical patent/CA2238723C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

(see formula I) Novel arylethenesulfonamide derivative having a high affinity for drugs, especially endoserine receptors, and represented by general formula (I); pharmaceutically acceptable salts thereof; and drugs comprising the same as the active ingredient, especially endoserine receptor antagonist, wherein Ar: optionally substituted aryl group or optionally substituted five- to six-membered heteroaryl group;
X: oxygen atom, sulfur atom or a group represented by a formula -NH-;
Y: oxygen atom or sulfur atom;
R1: hydrogen atom, optionally halogen-substituted lower alkyl group, cycloalkyl group, optionally substituted aryl group or optionally substituted five- to six-membered heteroaryl group;

R2: lower alkyl group, lower alkenyl group or lower alkynyl group where each of which may be substituted with one to three substituent(s) selected from a group consisting of hydroxyl group, lower alkoxy group, cycloalkyl group, halogen atom, carboxyl group and lower alkoxycarbonyl group;
R3: phenyl group which may be substituted with one to four substituent(s) selected from a group consisting of optionally halogen-substituted lower alkyl group, lower alkoxy group, halogen atom, lower alkylthio group, lower alkylsulfinyl group, lower alkanesulfonyl group, carboxyl group, lower alkoxycarbonyl group and carbamoyl group; and R4 and R5: they may be same or different and each is hydrogen atom or lower alkyl
CA002238723A 1995-12-20 1996-12-19 Arylethenesulfonamide derivatives and drug composition containing the same Expired - Fee Related CA2238723C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPHEI-7-332111 1995-12-20
JP33211195 1995-12-20
PCT/JP1996/003701 WO1997022595A1 (en) 1995-12-20 1996-12-19 Arylethenesulfonamide derivatives and drug composition containing the same

Publications (2)

Publication Number Publication Date
CA2238723A1 true CA2238723A1 (en) 1997-06-26
CA2238723C CA2238723C (en) 2006-06-13

Family

ID=36587553

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002238723A Expired - Fee Related CA2238723C (en) 1995-12-20 1996-12-19 Arylethenesulfonamide derivatives and drug composition containing the same

Country Status (1)

Country Link
CA (1) CA2238723C (en)

Also Published As

Publication number Publication date
CA2238723C (en) 2006-06-13

Similar Documents

Publication Publication Date Title
IL145192A0 (en) Pyrimidine compounds
AU1171097A (en) Arylethenesulfonamide derivatives and drug composition containing the same
PT1286998E (en) OXAZOLIDINONE DERIVATIVES WITH ANTIBIOTIC ACTIVITY
CA2262502A1 (en) 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and pharmaceutical composition containing the same
WO2001009103A3 (en) Imidazole antiproliferative agents
DE69021472D1 (en) Pyrazole derivatives, processes for their preparation and pharmaceutical compositions containing them.
CA2237005A1 (en) Quinazoline derivatives
DE69505968T2 (en) AZOLIDINDION DERIVATIVES AND THEIR USE AS ANTI-HYPERGLYCEMAS
AU5910996A (en) Pyrrole derivatives and medicinal composition
IL125982A0 (en) 2-(arylphenyl) amino-imidazoline derivatives
EP1537879A4 (en) Preventive and/or therapeutic drugs for asthma
CA2238723A1 (en) Arylethenesulfonamide derivatives and drug composition containing the same
CA2382654A1 (en) Novel a-500359 derivatives
CA2088702A1 (en) Aminobenzoic acid derivatives
ATE170851T1 (en) GUANIDINOTHIAZOLE DERIVATIVES AND THEIR USE AS H2 RECEPTOR ANTAGONISTS
EP1219619A4 (en) Piperidine derivatives
MX9806341A (en) Heterocyclyl-ergoline derivatives as 5-ht1a receptor ligands.
EP1352906A4 (en) Compositions for prevention or treatment of hepatopathy
PL377530A1 (en) Imidazol derivatives having affinity for alpha 2 receptors activity
EP1227098A4 (en) Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents
CA2129813A1 (en) 5-aminoflavone derivatives

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed